All funding questions have been answered, non-dilutive, multiple products will be on the market, and it is very likely CLDX will be well in the green, fully owning all of its platform. Last spring, they took a little uncertainty off the table with a secondary and the stock quadrupled. This one takes virtually all uncertainty off the table. This one is a major game changer. I said it last time, I say it again - you will never see these levels again. This dramatically increases my price view moving forward.
CLDX has never been in as good shape as it is now...any CEO who wants CLDX now would have little trouble selling his BOD! That is now my greatest FEAR... not drug trial failures, personnel decisions, strategy and or tactics..and the sp at the time of merger would be $35 w/ only 40% upside so $52 in a Buyout!
Frank, What are you talking about? Takeover at 52.00? How precisely does that work? You really think that AM would accept that, or he will simply h ave no choice as his hand will be forced as part of a hostile takeover? Sorry, pal you are WAY OFF on this one. Must be too much beer and football lol
you are insane guys. no way AM and company sell out for $52 / share. Forget that. If anyone thought they coudl get Celldex for $52 it would be done alreadyy. The reality is that a $25/share premium would only be possible if a company had leverage it make it happen. Perhaps if they had a partnership deal in place for the compound with greatest potential. But nobody does and I think we should reject anything short of $100 today ($8BB enterprise value).
Fraz, if the majority of the trials look good with very little failure then I think we would see more than $52 in a buyout….we would most likely see a bidding war, or maybe Marucci and BOD have no interest in selling and truly want to go this on there on!